Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | TRPM8 | Q7Z2W7 | 5/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6428799 | 1.00 | DNM1 (0.40) | DNM1TSHRTHRBTRPM8OPRM1 | |
| SCHEMBL17529897 | 1.00 | DNM1 (0.40) | DNM1TSHRTHRBTRPM8OPRM1 | |
| SCHEMBL17529780 | 1.00 | DNM1 (0.40) | DNM1TSHRTHRBTRPM8OPRM1 | |
| SCHEMBL7182029 | 0.97 | DNM1 (0.36) | DNM1TSHRTHRBTRPM8OPRM1 | |
| SCHEMBL17529735 | 0.95 | DNM1 (0.40) | DNM1TSHRTHRBTRPM8OPRM1 | |
| SCHEMBL17529830 | 0.95 | DNM1 (0.40) | DNM1TSHRTHRBTRPM8OPRM1 | |
| SCHEMBL17529774 | 0.95 | DNM1 (0.40) | DNM1TSHRTHRBTRPM8OPRM1 | |
| SCHEMBL17529870 | 0.92 | DNM1 (0.36) | DNM1TSHRTHRBTRPM8OPRM1 | |
| SCHEMBL17529782 | 0.90 | DNM1 (0.32) | DNM1TSHRTHRBTRPM8OPRM1 | |
| SCHEMBL5599468 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8633336-B2 | Method for separating a carboxylic acid in salified form bearing at least one halogen atom | RHODIA OPERATIONS (FR) | 2014-01-21 | — | — | US | claimed |
| US-20110166385-A1 | METHOD FOR SEPARATING A CARBOXYLIC ACID IN SALIFIED FORM BEARING AT LEAST ONE HALOGEN ATOM | RHODIA OPERATIONS (FR) | 2011-07-07 | — | — | US | claimed |
| US-20130131375-A1 | PROCESS FOR PREPARING DIFLUOROACETIC ACID, SALTS THEREOF OR ESTERS THEREOF | RHODIA OPERATIONS (FR) | 2013-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166385-A1 | METHOD FOR SEPARATING A CARBOXYLIC ACID IN SALIFIED FORM BEARING AT LEAST ONE HALOGEN ATOM | CA7, CA9, CA6 | DNM1 1253/4885TSHR 3277/4885THRB 3162/4885 |
| US-20130131375-A1 | PROCESS FOR PREPARING DIFLUOROACETIC ACID, SALTS THEREOF OR ESTERS THEREOF | FAH, KRAS, RARA | DNM1 673/4885TSHR 2274/4885THRB 2143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.